Your browser doesn't support javascript.
loading
A novel ceftazidime/avibactam, rifabutin, tedizolid and moxifloxacin (CARTM) regimen for pulmonary Mycobacterium avium disease.
Deshpande, Devyani; Srivastava, Shashikant; Pasipanodya, Jotam G; Lee, Pooi S; Gumbo, Tawanda.
Affiliation
  • Deshpande D; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, TX, USA.
  • Srivastava S; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, TX, USA.
  • Pasipanodya JG; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, TX, USA.
  • Lee PS; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, TX, USA.
  • Gumbo T; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, TX, USA.
J Antimicrob Chemother ; 72(suppl_2): i48-i53, 2017 Sep 01.
Article in En | MEDLINE | ID: mdl-28922809

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mycobacterium avium Complex / Mycobacterium avium-intracellulare Infection / Lung Diseases / Anti-Bacterial Agents / Models, Biological Limits: Humans Language: En Journal: J Antimicrob Chemother Year: 2017 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mycobacterium avium Complex / Mycobacterium avium-intracellulare Infection / Lung Diseases / Anti-Bacterial Agents / Models, Biological Limits: Humans Language: En Journal: J Antimicrob Chemother Year: 2017 Document type: Article Affiliation country: United States Country of publication: United kingdom